Atlas Trials

Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)

Clinical trial NCT00782561 · TERMINATED

Trial details

NCT number
NCT00782561
Sponsor
Kyntra Bio
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Focal Segmental Glomerulosclerosis
Start date
2008-04-01
Primary completion
2009-06-18
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.